STAT3 and glioblastoma: The present study provides new insights that we believe will be helpful in controlling the side effects of GBM radiotherapy associated with mortality, by targeting the increase in irradiated GBM-derived exosomal PAI-1 expression, activation of intracellular PAI-1 downstream STAT3 pathway, and disruption of muscle homeostasis in skeletal muscles.